ArticleLeukemia research reports2026

T-cell receptor anti-CMV CDR3s from bone marrow samples are associated with a worse overall survival for recurrent acute myeloid leukemia.

Srijit Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.